| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701965 | Journal of Thoracic Oncology | 2017 | 36 Pages |
Abstract
HC-based NGS influenced treatment decisions in close to half of the patients with lung adenocarcinoma and was associated with an overall response rate of 65%, which may translate into a survival benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anna Belilovski MD, Maya PhD, Elizabeth MD, Addie MSc, Lior PhD, Smadar MSc, Nir MD, PhD,